NEK11 controls degradation of CDC25A by directly phosphorylating CDC25A on residues whose phosphorylation is required for beta-TrCP mediated CDC25A polyubiquitylation and degradation.
Clinical trial and genome-wide association study of gene-disease association gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)
We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.